Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer
Sign Up to like & getrecommendations! Published in 2019 at "JAMA Pediatrics"
DOI: 10.1001/jamapediatrics.2019.0070
Abstract: In resource-rich countries, 5-year survival rates for children with cancer approach 85%. This impressive statistic is largely the result of integrating research with clinical care. At the core of this endeavor are multiagent combination chemotherapy… read more here.
Keywords: essential medicines; chemotherapy supportive; supportive care; cancer ... See more keywords
Stakeholder perspectives on the challenges surrounding management and supply of essential medicines
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Clinical Pharmacy"
DOI: 10.1007/s11096-019-00889-1
Abstract: Background Shortages of essential medicines impact patient safety and raise the costs of medicines to consumers and governments. Ongoing medicine shortages have become a critical issue that threaten global access to medicines. Objective The aim… read more here.
Keywords: challenges surrounding; supply; perspectives challenges; medicine ... See more keywords
Essential medicines availability is still suboptimal in many countries: a scoping review.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of clinical epidemiology"
DOI: 10.1016/j.jclinepi.2018.02.006
Abstract: OBJECTIVES To identify uses of WHO Model list of essential medicines (EMs) and summarize studies examining EM and national EM lists (NEMLs). STUDY DESIGN AND SETTING In this scoping review, we searched PubMed, Scopus, WHO… read more here.
Keywords: availability; scoping review; still suboptimal; essential medicines ... See more keywords
Are essential medicines available, reliable and affordable in low-middle income countries?
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cancer Policy"
DOI: 10.1016/j.jcpo.2018.12.001
Abstract: Abstract A critical challenge for reducing the cancer survival disparity between children living in low-middle income countries (LMICs) and those in high income countries (HICs) is the apparent lack of consistent supplies of reliable, good… read more here.
Keywords: middle income; cancer; essential medicines; income countries ... See more keywords
The Discriminatory Power of the BCS-Based Biowaiver: AÂ Retrospective With Focus on Essential Medicines.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of pharmaceutical sciences"
DOI: 10.1016/j.xphs.2019.04.030
Abstract: This article summarizes historic developments, recent expert opinions, and (currently) unresolved challenges concerning the Biopharmaceutics Classification System (BCS)-based Biowaiver. An overview of approval statistics and application potential, case examples addressing the discriminatory power of the… read more here.
Keywords: essential medicines; bcs based; based biowaiver; discriminatory power ... See more keywords
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level
Sign Up to like & getrecommendations! Published in 2022 at "Epidemiology and Psychiatric Sciences"
DOI: 10.1017/s2045796022000087
Abstract: Abstract Aims To provide a cross-country analysis of selection, availability, prices and affordability of essential medicines for mental health conditions, aiming to identify areas for improvement. Methods We used the World Health Organization (WHO) online… read more here.
Keywords: health; income countries; essential medicines; availability ... See more keywords
Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-03772-0
Abstract: Although polypharmacy is common among patients on hemodialysis (HD), its association with prognosis remains unclear. This study aimed to elucidate the association between the number of prescribed medicines and all-cause mortality in patients on HD,… read more here.
Keywords: non essential; patients hemodialysis; prognostic impact; essential medicines ... See more keywords
How can biosimilars change the trajectory of breast cancer therapy?
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2020.1757438
Abstract: The clinical development and use of biologic agents, or biologics, has successfully improved outcomes in several lifethreatening diseases, including malignancies. In cancer medicine, the development of biologics has significantly expanded the availability of valuable options… read more here.
Keywords: therapy; essential medicines; breast cancer; cancer ... See more keywords
Access to medicines through health systems in low- and middle-income countries
Sign Up to like & getrecommendations! Published in 2019 at "Health Policy and Planning"
DOI: 10.1093/heapol/czz119
Abstract: Abstract Nearly 2 billion people globally have no access to essential medicines. This means essential medicines are unavailable, unaffordable, inaccessible, unacceptable or of low quality for more than a quarter of the population worldwide. This… read more here.
Keywords: low middle; essential medicines; medicines health; health systems ... See more keywords
Addition of direct oral anticoagulants to the World Health Organization model list of essential medicines for the treatment of atrial fibrillation: An African perspective
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15226
Abstract: Atrial fibrillation (AF) is a major cause of adverse cardiovascular outcomes, and its prevalence is fast rising in Africa. The advent of direct oral anticoagulants (DOACs) has been a major revolution for the prevention of… read more here.
Keywords: list essential; essential medicines; direct oral; oral anticoagulants ... See more keywords
Roche asks WHO to remove Avastin from essential medicines list
Sign Up to like & getrecommendations! Published in 2017 at "British Medical Journal"
DOI: 10.1136/bmj.j779
Abstract: The Swiss drug company Roche has applied to have its drug bevacizumab (marketed as Avastin) taken off the World Health Organization’s list of essential medicines as an ophthalmic treatment. Every two years a WHO expert… read more here.
Keywords: roche asks; asks remove; remove avastin; essential medicines ... See more keywords